Jyothy Labs reports double-digit growth beyond Pril in Q2 FY27

Jyothy Labs reported double-digit Q2 FY27 growth in fabric care, home care excluding Pril and personal care, led by 15.3% growth in home care excluding Pril. Fabric care grew 10.4% and personal care rose 11.2%, while consolidated revenue from operations increased 3.3% year on year to Rs 760 crore.

How fast did Jyothy Labs’ categories grow in Q2 FY27?

Jyothy Labs’ fastest-growing reported category in Q2 FY27 was home care excluding Pril, which increased 15.3%, followed by personal care at 11.2% and fabric care at 10.4%. The company identifies Ujala and Henko within fabric care, EXO and maxo within home care, and Margo within personal care. Each of these reported category measures increased by more than 10% during the quarter.

Fabric care’s 10.4% Q2 FY27 growth was below its 12.3% growth for H1 FY27, while home care excluding Pril accelerated to 15.3% in Q2 from 8.8% for the half year. Personal care also recorded a higher Q2 rate of 11.2% than its 5.4% H1 FY27 growth. In contrast, home care including Pril declined 7.1% in Q2 and 8.1% in H1 FY27.

Why did Jyothy Labs’ overall revenue growth trail category growth?

Jyothy Labs’ revenue from operations rose 3.3% year on year to Rs 760 crore in Q2 FY27, below the 10.4% to 15.3% growth reported in fabric care, home care excluding Pril and personal care. The company separately reported value growth of 12.4% and volume growth of 8.1% for revenue excluding Pril and Fa during the quarter. This disclosure separates the remaining portfolio’s reported growth from sales associated with Pril and Fa.

The category comparison illustrates the difference: home care including Pril declined 7.1% in Q2 FY27, whereas home care excluding Pril grew 15.3%, a 22.4-percentage-point gap. Jyothy Labs states that the asterisked category figures include Pril and Fa sales up to 31 May 2026. The company reported 12.4% ex-Pril-and-Fa value growth against 3.3% consolidated revenue growth in Q2 FY27.

How does Jyothy Labs’ Q2 growth compare with longer-term rates?

Jyothy Labs’ Q2 FY27 growth exceeded the three-year compound annual growth rate, or CAGR, in fabric care, home care excluding Pril and personal care. Fabric care grew 10.4% in Q2 FY27 compared with a 5.5% three-year CAGR, while home care excluding Pril grew 15.3% compared with a 3.3% three-year CAGR. CAGR is the annualised rate of change over the stated multi-year period.

Personal care increased 11.2% in Q2 FY27, compared with a 0.5% three-year CAGR and a 5.6% four-year CAGR. Fabric care’s four-year CAGR was 6.9%, while home care excluding Pril recorded 4.7%. Home care including Pril remained the exception, reporting a negative 3.3% three-year CAGR, a negative 0.5% four-year CAGR and a 7.1% Q2 FY27 decline.

What happened to Jyothy Labs’ Q2 margins and profit?

Jyothy Labs reported a lower Q2 FY27 gross margin of 34.8%, versus 48.1% in the same period a year earlier, while operating earnings before interest, tax, depreciation and amortisation, or EBITDA, margin declined to 2.5% from 16.1%. The company attributed the gross-margin decline to abnormal inflation in raw materials and packaging costs.

Operating EBITDA fell 83.8% year on year to Rs 19.2 crore from Rs 118.3 crore, and profit after tax, or PAT, declined 87.9% to Rs 10.6 crore from Rs 87.8 crore. Advertising and promotion, or A&P, spending was Rs 56.5 crore, equal to 7.4% of revenue from operations, compared with Rs 61.5 crore, or 8.4%, a year earlier. Jyothy Labs’ EBITDA bridge attributes 13.3 percentage points of the Q2 margin movement to gross margin, partly offset by a 0.9-percentage-point benefit from advertisement and sales promotion.

What does the H1 FY27 comparison show for Jyothy Labs?

Jyothy Labs reported H1 FY27 revenue from operations of Rs 1,533 crore, up 3.1% from Rs 1,487 crore, while revenue excluding Pril and Fa increased 10.2% in value and 6.2% in volume. The same divergence appeared in Q2 FY27, when consolidated revenue increased 3.3% and the ex-Pril-and-Fa value measure rose 12.4%.

For H1 FY27, gross margin was 36.7%, down from 48.0% in the prior-year period, and operating EBITDA was Rs 83.9 crore, down 65.4% from Rs 242.4 crore. PAT was Rs 58.2 crore, compared with Rs 184.6 crore a year earlier. Jyothy Labs reported a cash balance of Rs 846 crore as of 30 September 2026, including fixed deposits and mutual fund investments, versus Rs 997 crore at 31 March 2026.

Conclusion

Jyothy Labs’ Q2 FY27 category data show a split between the reported growth of fabric care, home care excluding Pril and personal care and the consolidated outcome. Home care excluding Pril grew 15.3%, ahead of personal care at 11.2% and fabric care at 10.4%, while revenue excluding Pril and Fa increased 12.4%. Total revenue, however, rose 3.3%, as home care including Pril declined 7.1%.

The next point to watch is whether the 15.3% home-care growth excluding Pril and 10.4% fabric-care growth continue while crude-linked and packaging-input inflation remains elevated. Jyothy Labs reported that inflation reduced Q2 FY27 gross margin by 13.3 percentage points year on year to 34.8%, with operating EBITDA margin at 2.5%.